Mission Impacts
The company's patented technology exemplifies cutting-edge advancements in nanomaterials, and aligns to the Bank's mission to drive innovation, helping to grow the Scottish economy and make it more competitive.
About iGii
iGii’s patented innovation, Gii™, is a 3D foam made from carbon atoms. It combines the desirable physical properties of graphene, such as sensitivity, flexibility and conductivity, without its scale-up and mass application challenges.
The cash injection will help iGii scale manufacturing of Gii-Sens™, its highly sensitive and accurate component for point-of-care diagnostic sensors. This application of Gii™ is experiencing strong demand globally due to its ability to deliver precise, laboratory-level results for a range of illnesses and indicators of illness, including cancers, pathogens, liver and heart failure.
Key Information
Key Quote
Jean-Christophe Granier, Chief Executive Officer at iGii said: “We are laser-focused on bringing our revolutionary Gii™ technology to markets, with immediate and significant opportunities in the healthcare sector. This additional funding will enable us to accelerate ongoing customer projects and invest in our reel-to-reel manufacturing capabilities to deliver commercial quantities of Gii™ worldwide for our customers. We are thrilled the Scottish National Investment Bank is supporting our ambitious growth plans and helping us export true Scottish innovation to the world. Together with our existing investors, we are transforming customers’ product performance and delivering life-changing benefits for people and our planet.”
Alignment to the United Nation's Sustainable Development Goals
Decent Work and Economic Growth
Industry, Innovation and Infrastructure
